Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting: proof-of-principle.
Show others and affiliations
2015 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 42, S246-S246 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Springer, 2015. Vol. 42, S246-S246 p.
National Category
Medical Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-176968ISI: 000363013201437OAI: oai:DiVA.org:kth-176968DiVA: diva2:883242
Conference
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), OCT 10-14, 2015, Hamburg, GERMANY
Note

QC 20151216

Available from: 2015-12-16 Created: 2015-11-13 Last updated: 2015-12-16Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Perols, AnnaKarlström, Amelie Eriksson
By organisation
Protein Technology
In the same journal
European Journal of Nuclear Medicine and Molecular Imaging
Medical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

Total: 105 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf